Cargando…

Hepatocyte-targeting and tumor microenvironment-responsive liposomes for enhanced anti-hepatocarcinoma efficacy

To increase the antitumor drug concentration in the liver tumor site and improve the therapeutic effects, a functionalized liposome (PPP-LIP) with tumor targetability and enhanced internalization after matrix metalloproteinase-2 (MMP2)-triggered cell-penetrating peptide (TATp) exposure was modified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Dongliang, Wen, Zhiwei, Chen, Hui, Lin, Shiyuan, Zhang, Wei, Tang, Xin, Wu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487930/ https://www.ncbi.nlm.nih.gov/pubmed/36104946 http://dx.doi.org/10.1080/10717544.2022.2122635

Ejemplares similares

Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM–camptothecin conjugate
por: Ma, Pengkai, et al.
Publicado: (2017)

Liposome cocktail activator modulates hepatocytes and remodels the microenvironment to mitigate acute liver failure
por: Yin, Na, et al.
Publicado: (2022)

CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
por: Digiacomo, Graziana, et al.
Publicado: (2022)

m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma
por: Li, Jianhao, et al.
Publicado: (2021)

Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma
por: Guo, Xian-ling, et al.
Publicado: (2012)

Molecular targeting of liposomal nanoparticles to tumor microenvironment
por: Zhao, Gang, et al.
Publicado: (2013)

Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2023)

Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro
por: Xia, Yu, et al.
Publicado: (2015)

Resveratrol Differentially Regulates NAMPT and SIRT1 in Hepatocarcinoma Cells and Primary Human Hepatocytes
por: Schuster, Susanne, et al.
Publicado: (2014)

Resveratrol differentially regulates NAMPT and SIRT1 in hepatocarcinoma cells and primary human hepatocytes
por: Schuster, Susanne, et al.
Publicado: (2014)

Clustering Nuclear Receptors in Liver Regeneration Identifies Candidate Modulators of Hepatocyte Proliferation and Hepatocarcinoma
por: Vacca, Michele, et al.
Publicado: (2014)

Correction to: Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro
por: Xia, Yu, et al.
Publicado: (2022)

Development a hyaluronic acid ion-pairing liposomal nanoparticle for enhancing anti-glioma efficacy by modulating glioma microenvironment
por: Yang, Liuqing, et al.
Publicado: (2018)

Midostaurin Modulates Tumor Microenvironment and Enhances Efficacy of Anti-PD-1 against Colon Cancer
por: Lai, Cheng-Ta, et al.
Publicado: (2022)

Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase
por: Wang, Yinghui, et al.
Publicado: (2021)

High efficacy and minimal peptide required for the anti-angiogenic and anti-hepatocarcinoma activities of plasminogen K5
por: Yang, Xia, et al.
Publicado: (2010)

Targeted blocking of CCR2 and CXCR2 improves the efficacy of transarterial chemoembolization of hepatocarcinoma
por: Tian, Zhiqiang, et al.
Publicado: (2022)

Enhanced anti-breast cancer efficacy of co-delivery liposomes of docetaxel and curcumin
por: Ye, Xi, et al.
Publicado: (2022)

Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment
por: LI, MINMIN, et al.
Publicado: (2016)

Synthesis and Anti-Hepatocarcinoma Effect of Amino Acid Derivatives of Pyxinol and Ocotillol
por: Zhang, Ying, et al.
Publicado: (2021)

Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells
por: López-Grueso, María José, et al.
Publicado: (2019)

Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines
por: Digiacomo, Graziana, et al.
Publicado: (2020)

Oleate ameliorates palmitate-induced reduction of NAMPT activity and NAD levels in primary human hepatocytes and hepatocarcinoma cells
por: Penke, Melanie, et al.
Publicado: (2017)

Cabazitaxel liposomes with aptamer modification enhance tumor-targeting efficacy in nude mice
por: Cheng, Yuzhu, et al.
Publicado: (2019)

Metastatic Hepatocarcinoma He/De Tumor Model in Rat
por: Trencsenyi, Gyorgy, et al.
Publicado: (2014)

Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarcinoma Model
por: Yang, Zhuoshun, et al.
Publicado: (2010)

Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8(+) T cell response
por: Wang, Bo, et al.
Publicado: (2015)

Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway
por: Dong, Hao, et al.
Publicado: (2017)

Bioactivity-guided isolation of antioxidant and anti-hepatocarcinoma constituents from Veronica ciliata
por: Yin, Li, et al.
Publicado: (2016)

Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Hepatocarcinoma
por: Wei, Juncheng, et al.
Publicado: (2021)

Microenvironment of Tumor-Draining Lymph Nodes: Opportunities for Liposome-Based Targeted Therapy
por: Chandrasekaran, Siddarth, et al.
Publicado: (2014)

Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment
por: Licarete, Emilia, et al.
Publicado: (2020)

Potent delivery of an MMP inhibitor to the tumor microenvironment with thermosensitive liposomes for the suppression of metastasis and angiogenesis
por: Lyu, Yaqi, et al.
Publicado: (2019)

Tankyrases/β-catenin Signaling Pathway as an Anti-proliferation and Anti-metastatic Target in Hepatocarcinoma Cell Lines
por: Huang, Jianghai, et al.
Publicado: (2020)

Metachronous pulmonary and adrenal metastases after liver transplantation for hepatocarcinoma
por: Chen, Shan-Wen, et al.
Publicado: (2011)

Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment
por: Owusu, Benjamin Yaw, et al.
Publicado: (2017)

Enhanced tumor accumulation and therapeutic efficacy of liposomal drugs through over-threshold dosing
por: Ao, Hui, et al.
Publicado: (2022)

Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice of Hepatocarcinoma Xenograft
por: Yu, XiaoXiao, et al.
Publicado: (2018)

Paradoxical role of autophagy in the dysplastic and tumor-forming stages of hepatocarcinoma development in rats
por: Sun, K, et al.
Publicado: (2013)

Targeting the Tumor Microenvironment with Fluorescence-Activatable Bispecific Endoglin/Fibroblast Activation Protein Targeting Liposomes
por: Tansi, Felista L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q702ekpk8ve0e32rdsbaep44no